BB&a;T
BB&a;T is a community bank that finances early and later stage venture investments.
Business Model:
Revenue: $13.8B
Employees: 10,001-999,999
Rankings
Industries / Tags:
Detailed BB&a;T Information
Geographic Data
Address: 200 W 2nd Street
City: Winston-Salem
State: NC
Zip: 27101
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
132,439Website Global Rank
775,774Website Monthly Traffic
Twitter Followers
Description
BB&a;T Corporation (NYSE: BBT) is a financial services holding companies in the U.S. with $181.1 billion in assets and market capitalization of $23.8 billion, as of Sept. 30, 2013. Based in Winston-Salem, N.C., the company operates approximately 1,824 financial centers in 12 states and Washington, D.C., and offers a full range of consumer and commercial banking, securities brokerage, asset management, mortgage and insurance products and services. A Fortune 500 company, BB&a;T is consistently recognized for outstanding client satisfaction by J.D. Power and Associates, the U.S. Small Business Administration, Greenwich Associates and others. BB&a;T&s;s banking subsidiaries are organized as a group of community banks, each with a regional president, which allows decisions to be made locally, close to the client. This also makes BB&a;T&s;s client service more responsive, reliable and empathetic.
Contact Phone:
+13367332000
Contact Email:
BB&a;T went public on 1/13/1978 on the NYSE
Listed Exchange:
NYSE
IPO Date:
1/13/1978
Ticker Symbol:
BBT
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2008 | CVRx | Series E | 0 |
| 5/2008 | Kythera Biopharmaceuticals | Series C | 0 |
| 9/2018 | Enigma Technologies | Series C | 0 |
| 4/2012 | OvaScience | Series B | 0 |
| 7/2019 | Stag Industrial | Post-IPO Debt | 0 |
| 9/2011 | Kythera Biopharmaceuticals | Series D | 0 |
| 7/2019 | Stag Industrial | Post-IPO Debt | 0 |
| 9/2018 | Enigma Technologies | Series C | 0 |
| 4/2012 | OvaScience | Series B | 0 |
| 9/2011 | Kythera Biopharmaceuticals | Series D | 0 |
| 7/2008 | CVRx | Series E | 0 |
| 5/2008 | Kythera Biopharmaceuticals | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
